Bexagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor used as an antidiabetic medication to improve glycemic control in adults with type 2 diabetes mellitus. This category provides essential… Read more
Bexagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor used as an antidiabetic medication to improve glycemic control in adults with type 2 diabetes mellitus. This category provides essential reference standards for the active pharmaceutical ingredient, alongside a comprehensive range of related compounds, including synthetic impurities, degradation products, and stable isotope-labelled standards. These materials are critical for pharmaceutical laboratories performing rigorous analytical testing, such as impurity profiling, method validation, and stability studies. The collection features various structural variants, including epimers, open-chain isomers, furanose forms, and acetylated derivatives, which are necessary for identifying and quantifying potential process-related impurities. Additionally, stable isotope-labelled compounds, such as deuterium-labelled versions of the drug, serve as vital internal standards for mass spectrometry-based bioanalytical assays, ensuring accuracy and precision in quality control and pharmacokinetic research.